Halle Kuykendall

机构：University of Colorado Cancer Center, University of Colorado Denver

发表论文 2 篇 · 总被引 10 次 · h-index 2

代表论文

• The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC (2024 · JTO Clinical and Research Reports · 被引 8)
• A phase 1/2, open label study of amivantamab in combination with tyrosine kinase inhibitors among participants with advanced NSCLC harboring ALK, ROS1, and RET gene fusions. (2024 · Journal of Clinical Oncology · 被引 2)